Novavax reports positive phase 1 data on its Covid-19 vaccine candidate
August 04, 2020 at 16:51 PM EDT
The study found the candidate to both be generally well-tolerated and elicit “robust antibody responses,” the company said Tuesday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|